Related Articles Are Institutions Funding AI Abundance or Catastrophe? Angelo Calvello Hedge Funds Look for Rare IPO to Extend Biopharma Rally Stephen Taub Short-Dated Options Draw Investors as Event Volatility Surges Sponsored by CME Group